Delivery Order SPE2DB20D2002-SPE2DB24FL63N

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,829.51, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 9, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a $36,865.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a period of performance through May 13, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,401.68, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules and has a completion date of September 20, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,282.72, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules in quantities of 100. The contract is a firm-fixed-price delivery order with a completion date of November 29, 2023. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,062.57, is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024, and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,973.90, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules in quantities of 100. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,559.24, is a firm fixed-price delivery order for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S. The contract has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,934.65, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2023. There is no set-aside designation mentioned in the information provided....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,807.37, is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. The contract is a Delivery Order under a Firm Fixed Price pricing type, with a completion date of March 14, 2025. The contract was awarded on March 13, 2025 and does not have a set-aside designation,...
This federal contract award, valued at $4,107.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a pharmaceutical product, with a completion date of June 23, 2025. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL63N
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.01, is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:54 AM